Ajinomoto Co., Inc.'s Twofold Nutraceutical Solution Targets Weight Management and Sleep Quality Improvement

FORT LEE, N.J., Oct. 11, 2011 /PRNewswire/ -- Ajinomoto Co., Inc., a leader in the development of pharmaceutical-quality amino acids and safe, effective nutraceutical solutions, is showcasing its patented Capsiate Natura® at the 61st Annual Obesity & Associated Conditions Symposium, in Las Vegas, NV,  October 28 -29.  

The first and only dietary supplement with natural capsinoids extracted from the CH-19 Sweet pepper, Capsiate Natura® is unique in addressing caloric output by boosting the body's metabolic rate* which is critical to overall weight management.  Glysom™, a nutraceutical sleep solution that represents the latest amino acid and sleep research, offers a holistic, side-effect free option for today's sleep quality improvement.

"The relationship between weight loss and sleep has been of increasing interest and importance to both medical researchers and practitioners," said Brendan Naulty, president of Ajinomoto Food Ingredients.  "Our safe, effective dietary supplements Capsiate Natura® and Glysom™ bridge the two areas for optimal benefit to the overall health."  

According to a recent study by Dr. Eve Van Cauter and associates at the University of Chicago, the effects of sleep loss are linked to an increase in hunger hormones and excessive caloric intake.(1) Additional research has shown that just one shortened night of sleep can increase caloric consumption by up to 500 additional calories, which equates to nearly an extra pound a week.(2)  Made from glycine, an amino acid that occurs naturally in the body, Glysom™ has been scientifically proven to promote deeper, sounder and more satisfying sleep and is particularly effective in promoting the non-REM sleep crucial to feeling refreshed in the morning*.  

"While Glysom™ can address the body's need for healthy deep sleep, Capsiate Natura® can help to increase its metabolism to burn more calories, which can be as important to weight management as diet and exercise," said Jun Tashiro, associate director of Ajinomoto U.S.A., Inc. "We look forward to presenting our unique dual nutraceutical solution to more medical professionals as this field develops."  

In addition to Capsiate Natura® and Glysom™, Ajinomoto Co., Inc. makes Natura Guard BP™, a milk protein-derived nutraceutical to help maintain healthy blood pressure levels already within the normal range*.  These products are substantiated through rigorous clinical studies and are available exclusively through medical professionals.  For more information and a complete list of healthcare professionals that carry Ajinomoto Food Ingredients' nutraceuticals, visit www.capsiatenatura.com, www.glysom.com and www.naturaguardbp.com.

About Ajinomoto Food Ingredients

Ajinomoto Food Ingredients delivers safe, effective ingredients whose functionality has been scientifically proven.  Our mission is the pursuit of better health through better nutrition.  Beginning with AJI-NO-MOTO® MSG, a highly versatile seasoning, our products have diversified to flavor seasonings (bonito, pork, chicken, and beef), sweeteners, savory sauces, enzymes, other food ingredients and nutritional supplements.  Based on the five basic tastes centering on Umami, Ajinomoto supplies ingredients with unique aroma, texture, kokumi (full-bodied taste) and nutritional functionality.  These ingredients make it possible for our customers to build strong brands and offer consumers great-tasting, nutritionally beneficial products.

About Ajinomoto Co., Inc.

Ajinomoto is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals.  For many decades, Ajinomoto has contributed to food culture and human health through wide-ranging application of amino acid technologies.  Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability.  Founded in 1909 and now operating in 26 countries, Ajinomoto had net sales of 1207.8 billion yen (14.2 billion USD) in fiscal 2010.  For more about Ajinomoto (TYO: 2802), visit www.ajinomoto.com.

Glysom™ and Capsiate Natura® clinical studies are available on request.

(1) Kristen L. K, Karine S, Plamen P, and Eve Van C. The Metabolic Consequences of Sleep Deprivation. Sleep Med Rev. 11 (2007): 163-178

(2) Benedict C, Hallschmid M, Lassen A, Mahnke C, Schultes B, Schioth HB, Born J, Lange T. Acute sleep deprivation reduces energy expenditure in healthy men. Am J Clin Nutr. 93(2011): 1229-36

*These statements have not been evaluated by the Food and Drug Administration.
These products are not intended to diagnose, treat, cure, or prevent any disease.

SOURCE Ajinomoto Co., Inc.